Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-235-5 | CAS number: 13703-82-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2018-08-30 - 2018-09-14
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- A temperature higher than 25°C was registered on 26 October 2017. The maximum value measured was 26°C. A relative humidity higher than 70% was registered on 06 November 2017. The maximum value measured was 92%.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- A temperature higher than 25°C was registered on 26 October 2017. The maximum value measured was 26°C. A relative humidity higher than 70% was registered on 06 November 2017. The maximum value measured was 92%.
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Groupe Interministeriel des Produits Chimiques
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- The Buehler assay is considered more suitable for the test item.
Test material
- Reference substance name:
- Magnesium metaborate
- EC Number:
- 237-235-5
- EC Name:
- Magnesium metaborate
- Cas Number:
- 13703-82-7
- Molecular formula:
- BHO2.1/2Mg
- IUPAC Name:
- magnesium metaborate
- Test material form:
- liquid
1
- Specific details on test material used for the study:
- For the purpose of the study, the test item was used freshly prepared in corn oil (Sigma, Batch No. MKCC0462) for the topical applications. This vehicle was chosen as it produced the most suitable formulation at the required concentration. The test material was diluted at 1.5%, 7.5% and 15% in corn oil.
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Remarks:
- Albino
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: albino guinea pigs of Dunkin-Hartley strain, supplied by Charles-River (69210 Saint-Germain-Nuelles, France)
- Females (if applicable) nulliparous and non-pregnant: [yes/no/not specified]
- Microbiological status of animals, when known:
- Age at study initiation: 4,5 or 6 weeks old
- Weight at study initiation:
- Housing: groups of 5 at the maximum in polycarbonate containers
- Diet (e.g. ad libitum): ad libitum, tap-water from public distribution system)
- Water (e.g. ad libitum): ad libitum, ENVIGO, 2040C
- Acclimation period: 5 days
- Indication of any skin lesions: no
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22° C ± 3° C
- Humidity (%): from 30 % to 70 %,
- Air changes (per hr): at least 10 cycles per hour
- Photoperiod (hrs dark / hrs light): circadian cycle (12 hrs day / 12 hrs darkness).
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 100% of corn oil, 0.5 mL
- Day(s)/duration:
- 3 topical applications at D0, D7 and D13
- Adequacy of induction:
- highest technically applicable concentration used
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 1.5 % test item in corn oil
- Day(s)/duration:
- 3 topical applications at D0, D7 and D13
- Adequacy of induction:
- highest technically applicable concentration used
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 7.5% test item in corn oil
- Day(s)/duration:
- 3 topical applications at D0, D7 and D13
- Adequacy of induction:
- highest technically applicable concentration used
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 15% of test item in corn oil
- Day(s)/duration:
- 3 topical applications at D0, D7 and D13
- Adequacy of induction:
- highest technically applicable concentration used
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 100% corn oil in 0.5ml
- Day(s)/duration:
- 3 topical applications at D0, D7 and D13
- Adequacy of induction:
- highest technically applicable concentration used
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 100% HCA in 0.5ml
- Day(s)/duration:
- 3 topical applications at D0, D7 and D13
- Adequacy of induction:
- highest technically applicable concentration used
Challengeopen allclose all
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 100% corn oil, 0.5 mL
- Day(s)/duration:
- 14 days, D27 and D35
- Adequacy of challenge:
- highest non-irritant concentration
- No.:
- #2
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 1.5% test item in corn oil
- Day(s)/duration:
- 14 days, D27 and D35
- Adequacy of challenge:
- highest non-irritant concentration
- No.:
- #3
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 7.5% test item in corn oil
- Day(s)/duration:
- 14 days, D27 and D35
- Adequacy of challenge:
- highest non-irritant concentration
- No.:
- #4
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 15% test item in corn oil
- Day(s)/duration:
- 14 days, D27 and D35
- Adequacy of challenge:
- highest non-irritant concentration
- No.:
- #5
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 100% corn oil in 0.5 ml
- Day(s)/duration:
- 14 days, D27 and D35
- Adequacy of challenge:
- highest non-irritant concentration
- No.:
- #6
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 50% HCA
- Day(s)/duration:
- 14 days, D27 and D35
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- Test item: 20
Solvent control item: 10
Negative control (corn oil): 10
Positive control (HCA): 10 - Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
After shearing of the scapular zone, the 3 local applications were performed on D0, D7 and D13 for 6 hours under occlusive dressing (25mm x 50mm non woven swab of 4-layer patch from MEDISTOCK held in contact with the skin by means of 50 mm wide hypoallergenic micropore™ adhesive tape from 3M and Blenderm™ from 3M).
- No. of exposures: 3 topical applications at D0, D7 and D13
- Exposure period: 6 hours
- Test groups: 20 guinea pigs (10 male and 10 female). Total of 3 test groups.
- Control group: 10 guinea pigs (5 male and 5 female)
- Solvent control item: 10 guinea pigs (5 male and 5 female)
- Postivie control group: 10 guinea pigs (5 male and 5 female)
- Duration: 13-days follwed by 13-day rest phase
- Concentrations: 1.5%, 7.5%, 15% test item diluted in corn oil.
B. CHALLENGE EXPOSURE
- No. of exposures: 2 challenges at D27 and D35
- Day(s) of challenge: 14th day
- Exposure period: 6 hours
- Test groups: 20 guinea pigs (10 male and 10 female). Total of 3 test groups.
- Control group: 10 guinea pigs (5 male and 5 female)
- Solvent control item: 10 guinea pigs (5 male and 5 female)
- Postivie control group: 10 guinea pigs (5 male and 5 female)
Concentrations:
- Test groups: 1.5%, 7.5%, 15% test item diluted in corn oil.
- Control group: 100% corn oil
- Solvent control item: HCA (50% in corn oil)
- Postivie control group: HCA (50% in corn oil
- Evaluation (hr after challenge): 24/48/72 hrs
C. RECHALLENGE EXPOSURE
Due to the absence of reaction in the positive control group and doubtful reactions in treated groups, a rechallenge was performed under the same experimental conditions after a rest phase of 7 days. - Challenge controls:
- The challenge phase of animals induced with the solvent control item conducted under occlusive dressing for 6 hours, consisted of a single topical application of the solvent control item at 100% and of a negative control (corn oil).
- Positive control substance(s):
- yes
- Remarks:
- alpha Hexylcinnamaldehyde, 10 animals
Results and discussion
- Positive control results:
- First challenge:
Due to the absence of reaction in the positive control group and doubtful reactions in treated groups, a rechallenge was performed under the same experimental conditions after a rest phase of 7 days.
Second challenge:
In the treated group 6 with the positive control, a discrete to intense erythema was noted in 80% (8/10), 60% (6/10) and 40% (4/10) of the animals, 24, 48 and 72 hours after the challenge phase, respectively, on the area challenged with HCA at 50%. No cutaneous reaction was recorded in animals for control group after the challenge phase, on the area challenged with HCAe at 50%.
In the treated group 2 (treatment 1.5%), no macroscopic cutaneous reactions attributable to allergy were observed 24, 48 and 72 hours following the removal of the occlusive dressing.In the naïve control group 1bis (associated with the treatment dose of 1.5%), no cutaneous intolerance reactions were observed.
In the treated group 3 (treatment 7.5%), a discrete to intense erythema was recorded in 10% (2/20), 15% (3/20), 10% (2/20) of the animals, 24, 48 and 72 hours after the challenge phase, respectively.
In the naïve control group 1bis (associated with the treatment dose of 7.5%), no cutaneous intolerance reactions were observed. It must be noted that only one animal (No. C4567) (1/20) showed a positive response during the 1st challenge and during the 2nd challenge. Only these reactions may be indicative of sensitisation. The other reactions should not be considered as indicative of sensitisation.
In the treated group 4 (treatment 15%), no macroscopic cutaneous reactions attributable to allergy were observed 24, 48 and 72 hours following the removal of the occlusive dressing. In the naïve control group 1bis (associated with the treatment dose of 15%), no cutaneous intolerance reactions were observed.
The test item is not considered to be a skin sensitizer when it was tested at 1.5%, 7.5% and 15% in corn oil.
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1.5%
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Clinical observations:
- discrete to moderate erythema
- Remarks on result:
- positive indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1.5%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- discrete to moderate erythema
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 1.5%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- discrete to moderate erythema
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 7.5%
- No. with + reactions:
- 5
- Total no. in group:
- 20
- Clinical observations:
- discrete erythema, moderate and confluent erythema, intense erythema and swelling
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 7.5%
- No. with + reactions:
- 1
- Total no. in group:
- 20
- Clinical observations:
- Intense erythema and swelling
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 7.5%
- No. with + reactions:
- 1
- Total no. in group:
- 20
- Clinical observations:
- discrete erythema
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 15%
- No. with + reactions:
- 6
- Total no. in group:
- 20
- Clinical observations:
- Discrete or patchy erythema; Moderate and confluent erythema
- Remarks on result:
- positive indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 15%
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Clinical observations:
- discrete to moderate erythema; Moderate and confluent erythema
- Remarks on result:
- positive indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No visible changes
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No visible changes
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No visible changes
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 50%
- No. with + reactions:
- 2
- Total no. in group:
- 10
- Clinical observations:
- discrete erythema
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No visible changes
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 72
- Group:
- positive control
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No visible changes
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1.5%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No cutaneous reaction
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1.5%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no cutaneous reaction
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 1.5%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No visible changes
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 7.5%
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Clinical observations:
- Moderate and confluent erythema; Intense erythema and swelling
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 7.5%
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Clinical observations:
- discrete to moderate erythema; Moderate and confluent erythema
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 7.5%
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Clinical observations:
- Discrete or patchy erythema
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 15%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No visible changes
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 15%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No visible changes
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 15%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No visible changes
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No visible changes
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No visible changes
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No visible changes
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 50%
- No. with + reactions:
- 8
- Total no. in group:
- 10
- Clinical observations:
- Discrete or patchy erythema; Moderate and confluent erythema; Intense erythema and swelling
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 50%
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Clinical observations:
- Discrete or patchy erythema; Moderate and confluent erythema
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- positive control
- Dose level:
- 50%
- No. with + reactions:
- 4
- Total no. in group:
- 10
- Clinical observations:
- Discrete or patchy erythema; Moderate and confluent erythema
- Remarks on result:
- positive indication of skin sensitisation
Any other information on results incl. tables
Weight evolution
No abnormalities and no differences in the body weight between the control and the treated group were observed.
Mortality
No mortality was registered during the main test.
Clinical signs
No abnormal clinical signs related to the administration of the test item were observed.
Table 1: Results from 1stChallenge
Treatment |
Time (hours) |
Concentration at Challenge |
Cutaneous Reaction |
% Positive responses ≥1 |
% of Sensitised Animals |
|||
0 |
1 |
2 |
3 |
|||||
Control |
24 |
1.5 |
10 |
0 |
0 |
0 |
0 |
0 |
48 |
10 |
0 |
0 |
0 |
0 |
0 |
||
72 |
10 |
0 |
0 |
0 |
0 |
0 |
||
24 |
7.5 |
10 |
0 |
0 |
0 |
0 |
0 |
|
48 |
10 |
0 |
0 |
0 |
0 |
0 |
||
72 |
10 |
0 |
0 |
0 |
0 |
0 |
||
24 |
15 |
10 |
0 |
0 |
0 |
0 |
0 |
|
48 |
10 |
0 |
0 |
0 |
0 |
0 |
||
72 |
10 |
0 |
0 |
0 |
0 |
0 |
||
24 |
Vehicle |
10 |
0 |
0 |
0 |
0 |
0 |
|
48 |
10 |
0 |
0 |
0 |
0 |
0 |
||
72 |
10 |
0 |
0 |
0 |
0 |
0 |
||
Test Material |
24 |
7.5 |
18 |
1 |
1 |
0 |
10 |
10 |
48 |
20 |
0 |
0 |
0 |
0 |
0 |
||
72 |
20 |
0 |
0 |
0 |
0 |
0 |
||
24 |
Vehicle |
10 |
3 |
7 |
0 |
50 |
50 |
|
48 |
20 |
0 |
0 |
0 |
0 |
0 |
||
72 |
20 |
0 |
0 |
0 |
0 |
0 |
||
Test Material |
24 |
7.5 |
15 |
2 |
2 |
1 |
25 |
25 |
48 |
19 |
0 |
0 |
1 |
5 |
5 |
||
72 |
19 |
1 |
0 |
0 |
5 |
5 |
||
24 |
Vehicle |
13 |
3 |
4 |
0 |
35 |
35 |
|
48 |
20 |
0 |
0 |
0 |
0 |
0 |
||
72 |
20 |
0 |
0 |
0 |
0 |
0 |
||
Test Material |
24 |
15 |
14 |
2 |
4 |
0 |
30 |
30 |
48 |
17 |
2 |
1 |
0 |
15 |
15 |
||
72 |
20 |
0 |
0 |
0 |
0 |
0 |
||
24 |
Vehicle |
13 |
4 |
3 |
0 |
35 |
35 |
|
48 |
19 |
1 |
0 |
0 |
5 |
5 |
||
72 |
20 |
0 |
0 |
0 |
0 |
0 |
||
Positive control |
24 |
50 |
10 |
0 |
0 |
0 |
0 |
|
48 |
10 |
0 |
0 |
0 |
0 |
|||
72 |
10 |
0 |
0 |
0 |
0 |
|||
24 |
0 |
8 |
1 |
1 |
0 |
20 |
||
48 |
10 |
0 |
0 |
0 |
0 |
|||
72 |
10 |
0 |
0 |
0 |
0 |
|||
Positive control |
24 |
50 |
8 |
0 |
2 |
0 |
20 |
20 |
48 |
10 |
0 |
0 |
0 |
0 |
0 |
||
72 |
10 |
0 |
0 |
0 |
0 |
0 |
||
24 |
0 |
5 |
1 |
4 |
0 |
50 |
50 |
|
48 |
9 |
1 |
0 |
0 |
10 |
10 |
||
72 |
10 |
0 |
0 |
0 |
0 |
0 |
Table 2: Results from 2ndChallenge
Treatment |
Time |
Concentration at Challenge |
Cutaneous Reaction |
% Positive responses ≥1 |
% of Sensitised Animals |
|||
0 |
1 |
2 |
3 |
|||||
Control (1 bis) |
24 |
1.5 |
10 |
0 |
0 |
0 |
0 |
|
48 |
10 |
0 |
0 |
0 |
0 |
|||
72 |
10 |
0 |
0 |
0 |
0 |
|||
24 |
7.5 |
10 |
0 |
0 |
0 |
0 |
||
48 |
10 |
0 |
0 |
0 |
0 |
|||
72 |
10 |
0 |
0 |
0 |
0 |
|||
24 |
15 |
10 |
0 |
0 |
0 |
0 |
||
48 |
10 |
0 |
0 |
0 |
0 |
|||
72 |
10 |
0 |
0 |
0 |
0 |
|||
24 |
Vehicle |
10 |
0 |
0 |
0 |
0 |
||
48 |
10 |
0 |
0 |
0 |
0 |
|||
72 |
10 |
0 |
0 |
0 |
0 |
|||
Test Material |
24 |
7.5 |
20 |
0 |
0 |
0 |
0 |
0 |
48 |
20 |
0 |
0 |
0 |
0 |
0 |
||
72 |
20 |
0 |
0 |
0 |
0 |
0 |
||
24 |
Vehicle |
20 |
0 |
0 |
0 |
0 |
0 |
|
48 |
20 |
0 |
0 |
0 |
0 |
0 |
||
72 |
20 |
0 |
0 |
0 |
0 |
0 |
||
Test Material |
24 |
7.5 |
18 |
0 |
1 |
0 |
10 |
10 |
48 |
18 |
1 |
2 |
0 |
15 |
15 |
||
72 |
18 |
2 |
0 |
0 |
10 |
10 |
||
24 |
Vehicle |
20 |
0 |
0 |
0 |
0 |
0 |
|
48 |
20 |
0 |
0 |
0 |
0 |
0 |
||
72 |
20 |
0 |
0 |
0 |
0 |
0 |
||
Test Material |
24 |
15 |
20 |
0 |
0 |
0 |
0 |
0 |
48 |
20 |
0 |
0 |
0 |
0 |
0 |
||
72 |
20 |
0 |
0 |
0 |
0 |
0 |
||
24 |
Vehicle |
20 |
0 |
0 |
0 |
0 |
0 |
|
48 |
20 |
0 |
0 |
0 |
0 |
0 |
||
72 |
20 |
0 |
0 |
0 |
0 |
0 |
||
Positive control |
24 |
50 |
10 |
0 |
0 |
0 |
0 |
|
48 |
10 |
0 |
0 |
0 |
0 |
|||
72 |
10 |
0 |
0 |
0 |
0 |
|||
24 |
0 |
10 |
0 |
0 |
0 |
0 |
||
48 |
10 |
0 |
0 |
0 |
0 |
|||
72 |
10 |
0 |
0 |
0 |
0 |
|||
Positive control |
24 |
50 |
2 |
1 |
6 |
1 |
80 |
80 |
48 |
4 |
3 |
3 |
0 |
60 |
60 |
||
72 |
6 |
2 |
2 |
0 |
40 |
40 |
||
24 |
0 |
10 |
0 |
0 |
0 |
0 |
0 |
|
48 |
10 |
0 |
0 |
0 |
0 |
0 |
||
72 |
10 |
0 |
0 |
0 |
0 |
0 |
||
Control Group |
24 |
Vehicle |
10 |
0 |
0 |
0 |
0 |
|
48 |
10 |
0 |
0 |
0 |
0 |
|||
72 |
10 |
0 |
0 |
0 |
0 |
|||
24 |
Vehicle |
10 |
0 |
0 |
0 |
0 |
||
48 |
10 |
0 |
0 |
0 |
0 |
|||
72 |
10 |
0 |
0 |
0 |
0 |
Applicant's summary and conclusion
- Interpretation of results:
- other: The test item is not considered to be a skin sensitizer.
- Conclusions:
- The test item is not considered to be a skin sensitizer when tested at 1.5%, 7.5%, and 15% in corn oil.
- Executive summary:
The aim of the study was to evaluate the possible allergenic activity of the test item magnesium metaborate and solvent control item after topical administration in guinea pigs. The experimental protocol was established according to OECD Guideline 406 and in compliance with GLP criteria.
According the results of the pretests, the induction phase (3 topical applications at 100%) under occlusive dressing was conducted with the test item to 20 guinea pigs and with the solvent control item to 10 guinea pigs and a 13-day rest phase. The challenge phase of animals induced with the test item conducted under occlusive dressing for 6 hours, consisted of a single topical application of the test item diluted at 50% in corn oil and of a negative control (corn oil).
The challenge phase of animals induced with the solvent control item conducted under occlusive dressing for 6 hours, consisted of a single topical application of the solvent control item at 100% and of a negative control (corn oil).
At the request of sponsor, a positive control group treated with a reference allergen alpha Hexylcinnamaldehyde was selected.
In the treated group 2 (treatment dose of 1.5%), a discrete to moderate erythema was recorded in 10% (2/20) of the animals, 24 hours after the challenge phase. No cutaneous reaction was noted 48 and 72 hours after the challenge phase. A discrete to moderate erythema was recorded in 50% (10/20) of the animals, 24 hours after the challenge phase on the treated area with corn oil. No cutaneous reaction was noted 48 and 72 hours after the challenge phase. In the control group 1 (associated with the treatment dose of 1.5%), no cutaneous reaction was noted after the challenge phase.
In the treated group 3 (treatment dose of 7.5%), a discrete to intense erythema was recorded in 25% (5/20), 5% (1/20), 5% (1/20) of the animals, 24, 48 and 72 hours, respectively, after the challenge phase. A discrete to moderate erythema was recorded in 35% (7/20) of the animals, 24 hours after the challenge phase on the treated area with corn oil. No cutaneous reaction was noted 48 and 72 hours after the challenge phase. In the control group 1 (associated with the treatment dose of 7.5%), no cutaneous reaction was noted after the challenge phase.
In the treated group 4 (treatment dose of 15%), a discrete to moderate erythema was recorded in 30% (6//20), 15% (3/20) of the animals, 24 and 48 hours, respectively, after the challenge phase. No cutaneous reaction was noted 72 hours after the challenge phase. A discrete to moderate erythema was recorded in 35% (7/20), 5% (1/20) of the animals, 24 and 48 hours, respectively, after the challenge phase on the treated area with corn oil. No cutaneous reaction was noted 72 hours after the challenge phase. In the control group 1 (associated with the treatment dose of 15%), no cutaneous reaction was noted after the challenge phase.
In the treated group 6 with the positive control, moderate erythema was noted in 20% (2/10), of the animals, 24 hours after the challenge phase, on the area challenged with alpha Hexylcinnamaldehyde at 50%. No cutaneous reaction was noted 48 and 72 hours after the challenge phase. A discrete to moderate erythema was recorded in 50% (5/10), 10% (1/10) of the animals, 24 and 48 hours after the challenge phase on the treated area with corn oil. No cutaneous reaction was noted 72 hours after the challenge phase. No cutaneous reaction was recorded in animals for control group 5 after the challenge phase, on the area challenged with alpha Hexylcinnamaldehyde at 50%. A discrete to moderate erythema was recorded in 20% (2/10) of the animals, 24 hours after the challenge phase on the treated area with corn oil. No cutaneous reaction was noted 48 and 72 hours after the challenge phase.
Due to the absence of reaction in the positive control group and doubtful reactions in treated groups, a rechallenge was performed under the same experimental conditions after a rest phase of 7 days.
Second challenge:
In the treated group 6 with the positive control, a discrete to intense erythema was noted in 80% (8/10), 60% (6/10) and 40% (4/10) of the animals, 24, 48 and 72 hours after the challenge phase, respectively, on the area challenged with HCA at 50%. No cutaneous reaction was recorded in animals for control group after the challenge phase, on the area challenged with HCAe at 50%.
In the treated group 2 (treatment 1.5%), no macroscopic cutaneous reactions attributable to allergy were observed 24, 48 and 72 hours following the removal of the occlusive dressing.In the naïve control group 1bis (associated with the treatment dose of 1.5%), no cutaneous intolerance reactions were observed.
In the treated group 3 (treatment 7.5%), a discrete to intense erythema was recorded in 10% (2/20), 15% (3/20), 10% (2/20) of the animals, 24, 48 and 72 hours after the challenge phase, respectively.
In the naïve control group 1bis (associated with the treatment dose of 7.5%), no cutaneous intolerance reactions were observed. It must be noted that only one animal (No. C4567) (1/20) showed a positive response during the 1st challenge and during the 2nd challenge. Only these reactions may be indicative of sensitisation. The other reactions should not be considered as indicative of sensitisation.
In the treated group 4 (treatment 15%), no macroscopic cutaneous reactions attributable to allergy were observed 24, 48 and 72 hours following the removal of the occlusive dressing. In the naïve control group 1bis (associated with the treatment dose of 15%), no cutaneous intolerance reactions were observed.
The test item is not considered to be a skin sensitizer when it was tested at 1.5%, 7.5% and 15% in corn oil.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.